Neurovita Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 5

Neurovita General Information

Description

Developer and manufacturer of medical devices focusing on high-end neuro-interventional devices. The company's products include the world's first NOVA intracranial drug-eluting stent system, the first domestic rapid exchange balloon Neuro RX for intracranial stenosis, and the domestic first low-name pressure rapid exchange balloon Neuro LPS for intracranial stenosis, providing clients more possibility to diagnosis and develop treatments for the patients.

Contact Information

Website
www.neurovitatech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 3 Factory Building, Shicheng Science and Technology Park, No. 1566, Yinzhong South Roa
  • Wuzhong Economic Development Zone
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Vertical(s)
Advanced Manufacturing, Digital Health, HealthTech
Corporate Office
  • No. 3 Factory Building, Shicheng Science and Technology Park, No. 1566, Yinzhong South Roa
  • Wuzhong Economic Development Zone
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurovita Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 07-Apr-2026 $14.5M Completed Profitable
1. Early Stage VC 01-Nov-2022 Completed Generating Revenue
To view Neurovita’s complete valuation and funding history, request access »

Neurovita Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Neurovita Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025152742-A1 Aneurysm occlusion apparatus and system for occluding aneurysm Pending 18-Jan-2024
WO-2025113719-A1 Aneurysm occlusion apparatus and system for aneurysm occlusion Inactive 29-Nov-2023
JP-2026521280-A Aneurysm occlusion device and system for occluding aneurysms Pending 29-Nov-2023
WO-2024174975-A1 Coated blood flow diverter, and preparation method and use Inactive 21-Feb-2023
EP-3789074-A1 Balloon catheter Active 28-Aug-2019 A61M25/10
To view Neurovita’s complete patent history, request access »

Neurovita Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurovita Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capitallink Venture Capital Minority
Chengdu Bio-Town Investment Government Minority
Daoyuan Capital Venture Capital Minority
Gongqingcheng Jingping Private Equity Fund Management Growth/Expansion Minority
Yiyuan Capital Growth/Expansion Minority
To view Neurovita’s complete investors history, request access »

Ready to get started?

Request a free trial

Neurovita FAQs

  • When was Neurovita founded?

    Neurovita was founded in 2020.

  • Where is Neurovita headquartered?

    Neurovita is headquartered in Suzhou, China.

  • What is the size of Neurovita?

    Neurovita has 200 total employees.

  • What industry is Neurovita in?

    Neurovita’s primary industry is Medical Supplies.

  • Is Neurovita a private or public company?

    Neurovita is a Private company.

  • What is the current valuation of Neurovita?

    The current valuation of Neurovita is .

  • What is Neurovita’s current revenue?

    The current revenue for Neurovita is .

  • How much funding has Neurovita raised over time?

    Neurovita has raised $13.9M.

  • Who are Neurovita’s investors?

    Capitallink, Chengdu Bio-Town Investment, Daoyuan Capital, Gongqingcheng Jingping Private Equity Fund Management, and Yiyuan Capital have invested in Neurovita.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process